jueves, 2 de julio de 2026

A Better Test for Finding Residual Pancreatic Cancer? Megan Brooks +++ +++ +++

A Better Test for Finding Residual Pancreatic Cancer? Megan Brooks https://www.medscape.com/viewarticle/better-test-finding-residual-pancreatic-cancer-2026a1000mjq?src= Clin Cancer Res. 2026; doi:10.1158/1078-0432.CCR-26-0609 AI May Help Predict Liver Cancer Risk in Young Adults Edited by Shrabasti Bhattacharya https://www.medscape.com/viewarticle/ai-may-help-predict-liver-cancer-risk-young-adults-2026a1000mio?src= Aliment Pharmacol Ther. 2026; doi:10.1111/apt.70732 Breast Cancer Incidence Rises in Asian American, Native Hawaiian, and Pacific Islander Women Edited by Gargi Mukherjee https://www.medscape.com/viewarticle/breast-cancer-incidence-rises-asian-american-native-hawaiian-2026a1000mhe?src= JAMA Netw Open. 2026;9(6):e2621250. doi:10.1001/jamanetworkopen.2026.21250 Asian Women With Breast Cancer Outlive White Peers Edited by Katie Lennon https://www.medscape.com/viewarticle/asian-women-breast-cancer-outlive-white-peers-2026a1000mcn?src= Biochem J. 1975;149(3):749-55. doi:10.1042/bj1490749 Q&A: Can More Patients With MIBC Keep Their Bladder? M. Alexander Otto, PA, MMSc https://www.medscape.com/viewarticle/q-can-more-patients-mibc-keep-their-bladder-2026a1000miy?src= July 02, 2026 Urgences 2026 How to Recognize Serious Pediatric Pain Fabienne Rigal https://www.medscape.com/viewarticle/translate-douleurs-p%C3%A9diatriques-aux-urgences-les-2026a1000mi3?src= What ASCO 2026 Taught Us About Scaling AI in Cancer Care Arturo Loaiza-Bonilla, MD, MSEd https://www.medscape.com/viewarticle/what-asco-2026-taught-us-about-scaling-ai-cancer-care-2026a1000l9c?src= FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD M. Alexander Otto, PA, MMSc https://www.medscape.com/viewarticle/fda-approves-orca%E2%80%91t-next%E2%80%91gen-hsct-reduce-2026a1000mg2 July 01, 2026 DISCOVER WHAT YOU CAN ASK MEDSCAPE AI https://www.medscape.com/ai-search?_gl=1*1hc3ubk*_gcl_au*NjkzMDY5MjIxLjE3ODA2NzA2MDAuMTQ5ODY4MjA4MC4xNzgyOTk5ODc5LjE3ODMwMDAzNTM.

No hay comentarios:

Publicar un comentario